Immunome IMNM Increase (Decrease) in Prepaid Expense and Other Assets
Increase (Decrease) in Prepaid Expense and Other Assets at other companies
Other financials
Where this comes from
Reported directly by Immunome in its filing.
Tagged under the XBRL concept us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets.
The official record: Immunome’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →
Ask your AI about Immunome's increase (decrease) in prepaid expense and other assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Immunome's increase (decrease) in prepaid expense and other assets?
- Immunome (IMNM) reported increase (decrease) in prepaid expense and other assets of $5.1M in Q1 2026.
- How has Immunome's increase (decrease) in prepaid expense and other assets changed year-over-year?
- Immunome's increase (decrease) in prepaid expense and other assets increased by 198.7% year-over-year, from $1.71M to $5.1M.
- What is the long-term trend for Immunome's increase (decrease) in prepaid expense and other assets?
- Over 2 years (2021 to 2023), Immunome's increase (decrease) in prepaid expense and other assets has grown at a -1.6% compound annual growth rate (CAGR), from $4.28M to $4.14M.
- What does increase (decrease) in prepaid expense and other assets mean?
- This tracks changes in cash paid in advance for goods or services that will be consumed in future periods. It reflects the timing difference between cash outflows and the recognition of related expenses on the income statement.